64 related articles for article (PubMed ID: 3771810)
1. Alprazolam kinetics in patients with renal insufficiency.
Ochs HR; Greenblatt DJ; Labedzki L; Smith RB
J Clin Psychopharmacol; 1986 Oct; 6(5):292-4. PubMed ID: 3771810
[TBL] [Abstract][Full Text] [Related]
2. Nitrazepam clearance unimpaired in patients with renal insufficiency.
Ochs HR; Oberem U; Greenblatt DJ
J Clin Psychopharmacol; 1992 Jun; 12(3):183-5. PubMed ID: 1629384
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of norfloxacin in chronic renal failure.
Arrigo G; Cavaliere G; D'Amico G; Passarella E; Broccali G
Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):491-6. PubMed ID: 4055162
[TBL] [Abstract][Full Text] [Related]
4. Oxaprozin pharmacokinetics in patients with congestive heart failure.
Ochs HR; Greenblatt DJ; Knüchel M
Arzneimittelforschung; 1986 Dec; 36(12):1837-40. PubMed ID: 3566846
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
Kowalsky SF; Echols RM; Parker MA
Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
[TBL] [Abstract][Full Text] [Related]
7. Butofilolol pharmacokinetics in chronic renal insufficiency.
Jeanniot JP; Houin G; Ledudal P; Cautreels W; Giudicelli CP; Tillement JP
Int J Clin Pharmacol Res; 1984; 4(3):165-73. PubMed ID: 6149194
[TBL] [Abstract][Full Text] [Related]
8. Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.
Smith RB; Gwilt PR; Wright CE
Clin Pharm; 1983; 2(2):139-43. PubMed ID: 6883942
[TBL] [Abstract][Full Text] [Related]
9. Alprazolam kinetics following sublingual and oral administration.
Scavone JM; Greenblatt DJ; Shader RI
J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
Viotte G; Leroy A; Godin M; Fillastre JP
Nouv Presse Med; 1982 Nov; 11(46):3414-8. PubMed ID: 7155849
[TBL] [Abstract][Full Text] [Related]
11. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
[TBL] [Abstract][Full Text] [Related]
13. The use of clofibrate in patients with renal insufficiency.
Viikari J; Anttila M; Kasanen A
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):77-80. PubMed ID: 6840929
[TBL] [Abstract][Full Text] [Related]
14. No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
Gillotin C; Bagnis C; Mamet JP; Peck RW; Deray G
Int J Clin Pharmacol Ther; 1997 Nov; 35(11):522-6. PubMed ID: 9401835
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure.
Rey E; d'Athis P; Richard MO; Fillastre JP; Olive G
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):648-52. PubMed ID: 6526539
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
[TBL] [Abstract][Full Text] [Related]
18. Effect of age, gender, and obesity on midazolam kinetics.
Greenblatt DJ; Abernethy DR; Locniskar A; Harmatz JS; Limjuco RA; Shader RI
Anesthesiology; 1984 Jul; 61(1):27-35. PubMed ID: 6742481
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure.
Davis PJ; Stiller RL; Cook DR; Brandom BW; Davin-Robinson KA
Anesth Analg; 1988 Mar; 67(3):268-71. PubMed ID: 2964213
[TBL] [Abstract][Full Text] [Related]
20. Alprazolam in end-stage renal disease: I. Pharmacokinetics.
Schmith VD; Piraino B; Smith RB; Kroboth PD
J Clin Pharmacol; 1991 Jun; 31(6):571-9. PubMed ID: 1880224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
